Abstract
This prospective, phase 2 study aimed at assessing the efficacy of accelerated fractionation radiation therapy by concomitant boosts (CBs) associated with chemoradiation therapy (CRT) of the whole pelvis, in improving the rate of pathological complete response (pCR) to treatment in patients with International Federation of Gynaecology and Obstetrics (FIGO) stage IB2-IVA locally advanced cervical cancer.
| Original language | English |
|---|---|
| Pages (from-to) | 778-785 |
| Number of pages | 8 |
| Journal | International Journal of Radiation Oncology Biology Physics |
| Volume | 90 |
| DOIs | |
| Publication status | Published - 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adenocarcinoma
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols
- Carcinoma, Squamous Cell
- Chemoradiotherapy, Adjuvant
- Cisplatin
- Deoxycytidine
- Dose Fractionation
- Drug Administration Schedule
- Female
- Fluorouracil
- Humans
- Hysterectomy
- Lymph Node Excision
- Middle Aged
- Pelvis
- Prospective Studies
- Radiotherapy, Conformal
- Survival
- Uterine Cervical Neoplasms
Fingerprint
Dive into the research topics of 'Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver